Dijck, Patrick VanSjollema, JelmerCammue, Bruno P.A.Lagrou, KatrienBerman, Judithd'Enfert, ChristopheAndes, David R.Arendrup, Maiken C.Brakhage, Axel A.Calderone, RichardCantón, EmiliaCoenye, TomCos, PaulCowen, Leah E.Edgerton, MiraEspinel-Ingroff, AnaFiller, Scott G.Ghannoum, MahmoudGow, Neil A RHaas, HubertusJabra-Rizk, Mary AnnJohnson, Elizabeth M.Lockhart, Shawn R.López-Ribot, José L.Maertens, JohanMunro, Carol A.Nett, Jeniel E.Nobile, Clarissa J.Pfaller, Michael A.Ramage, GordonSanglard, DominiqueSanguinetti, MaurizioSpriet, IsabelVerweij, Paul E.Warris, AdiliaWauters, JoostYeaman, Michael R.Zaat, Sebastian A.J.Thevissen, Karin2018-06-202018-06-202018-07Dijck, P V, Sjollema, J, Cammue, B P A, Lagrou, K, Berman, J, d'Enfert, C, Andes, D R, Arendrup, M C, Brakhage, A A, Calderone, R, Cantón, E, Coenye, T, Cos, P, Cowen, L E, Edgerton, M, Espinel-Ingroff, A, Filler, S G, Ghannoum, M, Gow, N A R, Haas, H, Jabra-Rizk, M A, Johnson, E M, Lockhart, S R, López-Ribot, J L, Maertens, J, Munro, C A, Nett, J E, Nobile, C J, Pfaller, M A, Ramage, G, Sanglard, D, Sanguinetti, M, Spriet, I, Verweij, P E, Warris, A, Wauters, J, Yeaman, M R, Zaat, S A J & Thevissen, K 2018, 'Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms', Microbial Cell, vol. 5, no. 7, pp. 300-326. https://doi.org/10.15698/mic2018.07.6382311-2638ORCID: /0000-0003-0761-1755/work/162729049http://hdl.handle.net/2164/10637KT acknowledges receipt of a mandate of Industrial Research Fund (IOFm/05/022). JB acknowledges funding from the European Research Council Advanced Award 3400867/RAPLODAPT and the Israel Science Foundation grant # 314/13 (www.isf.il). NG acknowledges the Wellcome Trust and MRC for funding. CD acknowledges funding from the Agence Nationale de Recherche (ANR-10-LABX-62-IBEID). CJN acknowledges funding from the National Institutes of Health R35GM124594 and R21AI125801. AW is supported by the Wellcome Trust Strategic Award (grant 097377), the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen MaCA: outside this study MaCA has received personal speaker’s honoraria the past five years from Astellas, Basilea, Gilead, MSD, Pfizer, T2Candida, and Novartis. She has received research grants and contract work paid to the Statens Serum Institute from Astellas, Basilea, Gilead, MSD, NovaBiotics, Pfizer, T2Biosystems, F2G, Cidara, and Amplyx. CAM acknowledges the Wellcome Trust and the MRC MR/N006364/1. PVD, TC and KT acknowledge the FWO research community: Biology and ecology of bacterial and fungal biofilms in humans (FWO WO.009.16N). AAB acknowledges the Deutsche Forschungsgemeinschaft – CRC FungiNet.27971068engantifungal susceptibility testingbiofilm inhibitionbiofilm eradicationantibiofilm material coatingin vivo modelsR MedicineEuropean Research Council3400867/RAPLODAPTWellcome Trust097377Medical Research Council (MRC)MR/N006364/1RJournal item10.15698/mic2018.07.63857